FDA didn't ask for it.

Product is off-market for years...

Why follow-up and spend money on seemingly needless task?

Either PFE was doing a DD and decided to cover all based including Exubera,

or the intent is to put additional pressure on Afrezza which showed in

all clinical trials to not increase lung cancer risk.

I agree that shorts will use this tidbit, and paid reporters will spin it out

of proportion. This could be combined by some loud PFE statement.

With Afrezza - manipulations never end...

E